Advertisement
U.S. markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.7800-0.0700 (-1.44%)
At close: 04:00PM EDT
4.7650 -0.02 (-0.31%)
After hours: 04:34PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.8500
Open4.8400
Bid4.7400 x 200
Ask4.7900 x 200
Day's Range4.7600 - 4.9450
52 Week Range3.5300 - 11.3600
Volume3,598,959
Avg. Volume8,685,914
Market Cap668.975M
Beta (5Y Monthly)1.58
PE Ratio (TTM)N/A
EPS (TTM)-5.4100
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NVAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novavax, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/05/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • Zacks

    Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study

    Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.

  • Motley Fool

    1 Beaten-Down Stock That's Still Not Worth Buying

    For this biotech, a rebound seems far too unlikely.

  • InvestorPlace

    7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode

    There’s a simple reason why short-squeeze stocks to buy represent a powerful catalyst: they’re intuitive and easier to engage. Buying something and hoping that it appreciates in value represents an organically sensible strategy. It’s the reason why people collect everything from baseball cards to luxury Swiss watches. Stated differently, it doesn’t take much to explain the rationale behind short-squeeze stocks to buy. On the other hand, shorting a stock represents an incredibly complex affair by